<DOC>
	<DOCNO>NCT00334984</DOCNO>
	<brief_summary>RATIONALE : Glutamine may help prevent mucositis , mouth sore , patient receive chemotherapy sarcoma . It yet know whether glutamine effective placebo prevent mucositis patient receive chemotherapy sarcoma . PURPOSE : This randomized clinical trial study glutamine see well work compare placebo prevent oral mucositis patient receive chemotherapy sarcoma .</brief_summary>
	<brief_title>Glutamine Preventing Oral Mucositis Patients Receiving Chemotherapy Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare efficacy new preparation glutamine ( AES-14 ) v placebo reduce incidence grade 3 4 chemotherapy-induced oral mucositis first course chemotherapy patient sarcomas . Secondary - Compare rate mucositis-related chemotherapy dose reduction subsequent course anthracycline-based chemotherapy patient treat AES-14 v placebo . - Compare rate mucositis-related delay chemotherapy administration next chemotherapy course patient treat AES-14 v placebo . - Compare rate systemic oral infection first course chemotherapy patient treat AES-14 v placebo . - Compare number day narcotic use mucositis-related pain first course chemotherapy patient treat AES-14 v placebo . - Determine inter-rater reliability caregiver nurse use modify Walsh scale . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord age ( 5-10 year v 11-18 year v 19-30 year ) diagnosis ( Ewing 's sarcoma v osteogenic sarcoma v rhabdomyosarcoma v sarcoma ) . Patients randomize 1 2 treatment arm . - Arm I ( glutamine [ AES-14 ] ) : Patients rinse oral AES-14 least 30 second swallow ( swish swallow ) three time daily begin day within 1 day start first course chemotherapy . Patients also undergo standard oral care regimen comprise brush teeth least twice daily , 30 minute take AES-14 , rinse water least twice daily . Treatment continue blood count recover patient 's total modified Walsh score ≤ 2 ( mucositis score ) . - Arm II ( placebo ) : Patients swish swallow oral placebo undergo standard oral care regimen arm I. Caregivers assess patient 's mouth daily patient receive study drug . Caregivers keep daily diary rating patient 's oral mucosal area degree pain , describe patient 's oral intake , document study drug use standardized oral care perform . PROJECTED ACCRUAL : A total 180 patient accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Histiocytoma</mesh_term>
	<mesh_term>Histiocytoma , Benign Fibrous</mesh_term>
	<mesh_term>Histiocytoma , Malignant Fibrous</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosed follow : Ewing 's sarcoma Osteogenic sarcoma Rhabdomyosarcoma Other sarcoma ( i.e. , fibrosarcoma synovial sarcoma ) Scheduled receive first course chemotherapy include ≥ 75 mg/m² anthracyclines Total modify Walsh score ≤ 2 ( mucositis score ) PATIENT CHARACTERISTICS : Must caregiver ( parent , relative , friend ) available perform daily mucositis assessment Bilirubin ≤ 1.5 time upper limit normal ( ULN ) ALT ≤ 5 time ULN Albumin ≥ 2 g/dL No history hypersensitivity know component AES14 PRIOR CONCURRENT THERAPY : No prior glutamine ( AES14 ) No prior concurrent head and/or neck radiation therapy No concurrent supplementation another glutamine product No concurrent agent mucositis prophylaxis</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>childhood fibrosarcoma</keyword>
	<keyword>childhood neurofibrosarcoma</keyword>
	<keyword>childhood synovial sarcoma</keyword>
	<keyword>chondrosarcoma</keyword>
	<keyword>localize osteosarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>localize Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>childhood alveolar soft-part sarcoma</keyword>
	<keyword>childhood angiosarcoma</keyword>
	<keyword>childhood epithelioid sarcoma</keyword>
	<keyword>childhood leiomyosarcoma</keyword>
	<keyword>childhood liposarcoma</keyword>
	<keyword>localize childhood malignant fibrous histiocytoma bone</keyword>
	<keyword>metastatic childhood malignant fibrous histiocytoma bone</keyword>
	<keyword>childhood malignant mesenchymoma</keyword>
	<keyword>dermatofibrosarcoma protuberans</keyword>
	<keyword>childhood desmoplastic small round cell tumor</keyword>
</DOC>